MediPurpose Giving Away Free Kindles at NANN 2011
Attendees Can Earn Entries by Evaluating the babyLance Heel Incision Device at MediPurpose Booth 436
Orlando, FL, September 08, 2011 --(PR.com)-- MediPurpose® today announced that it will award free Amazon Kindle e-book readers in daily drawings at the NANN 27th Annual Conference in Orlando, September 14-16.
A drawing will be held at the end of the opening reception on Wednesday (5:30-7:30 p.m.) and after each exhibit hall session on Thursday and Friday (10 a.m.-2 p.m.). Winners will be able to claim their prizes immediately.
To earn entry into the drawings, registered NANN attendees must complete a brief written or video evaluation of the babyLance® infant heel incision device at MediPurpose’s exhibitor booth 436.
This is the second year that MediPurpose has hosted an educational booth at the NANN conference. Last year, approximately 200 neonatal nurses and other guests visited the company’s booth.
About babyLance Heel Sticks
A complement to the company’s vastly popular line of SurgiLance® safety lancets, babyLance® is a safe, easy and effective solution for newborn heel incisions.
Launched in July 2010, babyLance® is MediPurpose’s entry into a U.S. heel incision device market that is estimated to annually generate $32 million in sales.
Although babyLance® serves a niche market in the United States, it has rapidly gained market acceptance in the European neonatal medical product markets, including Austria, France, Italy, Spain and the United Kingdom.
“Although competition for neonatal heel sticks is fierce, there remains very high receptivity for a new heel incision device that can reduce bruising and trauma to the incision site while providing neonatal nurse safety,” said MediPurpose President and CSO Randy Prather. “Every feature of our heel stick was designed with those thoughts in mind.”
Prather added that babyLance® owes its popularity to other features that include:
* Ease of activation: Reduces trigger activation force, thereby significantly reducing the risk of bruising.
* Unique positioning design: Facilitates a stable and accurate placement against the targeted section of the infant’s heel while ensuring the procedure can be performed consistently and quickly.
* Compliance with regulatory and quality standards: Manufactured to the same regulatory and quality standards as the SurgiLance® safety lancet, the babyLance® cutting blade’s swift pendulum action makes an incision that complies with the CLSI LA4-A5 established guidelines.
* Cost effectiveness: The babyLance® heel incision device incorporates unique design characteristics that allow for the most cost-effective manufacturing process.
More information about babyLance®--including demonstration videos and no-cost product sample requests--is available at http://www.medipurpose.com/babylance/ .
About NANN
The National Association of Neonatal Nurses (NANN) was formed in 1984 with the purpose of addressing the educational and practice needs within the evolving specialty of neonatal nursing, while giving all neonatal nurses national representation.
For more information about NANN, please visit http://www.nann.org .
About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular babyLance® heel incision device, SurgiLance® safety lancet and MediPlus™ advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and medical product distributors.
MediPurpose's Medical Device Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.
For more information about MediPurpose’s medical products and solutions for inventors, innovators, manufacturers and distributors, please visit http://www.medipurpose.com .
###
A drawing will be held at the end of the opening reception on Wednesday (5:30-7:30 p.m.) and after each exhibit hall session on Thursday and Friday (10 a.m.-2 p.m.). Winners will be able to claim their prizes immediately.
To earn entry into the drawings, registered NANN attendees must complete a brief written or video evaluation of the babyLance® infant heel incision device at MediPurpose’s exhibitor booth 436.
This is the second year that MediPurpose has hosted an educational booth at the NANN conference. Last year, approximately 200 neonatal nurses and other guests visited the company’s booth.
About babyLance Heel Sticks
A complement to the company’s vastly popular line of SurgiLance® safety lancets, babyLance® is a safe, easy and effective solution for newborn heel incisions.
Launched in July 2010, babyLance® is MediPurpose’s entry into a U.S. heel incision device market that is estimated to annually generate $32 million in sales.
Although babyLance® serves a niche market in the United States, it has rapidly gained market acceptance in the European neonatal medical product markets, including Austria, France, Italy, Spain and the United Kingdom.
“Although competition for neonatal heel sticks is fierce, there remains very high receptivity for a new heel incision device that can reduce bruising and trauma to the incision site while providing neonatal nurse safety,” said MediPurpose President and CSO Randy Prather. “Every feature of our heel stick was designed with those thoughts in mind.”
Prather added that babyLance® owes its popularity to other features that include:
* Ease of activation: Reduces trigger activation force, thereby significantly reducing the risk of bruising.
* Unique positioning design: Facilitates a stable and accurate placement against the targeted section of the infant’s heel while ensuring the procedure can be performed consistently and quickly.
* Compliance with regulatory and quality standards: Manufactured to the same regulatory and quality standards as the SurgiLance® safety lancet, the babyLance® cutting blade’s swift pendulum action makes an incision that complies with the CLSI LA4-A5 established guidelines.
* Cost effectiveness: The babyLance® heel incision device incorporates unique design characteristics that allow for the most cost-effective manufacturing process.
More information about babyLance®--including demonstration videos and no-cost product sample requests--is available at http://www.medipurpose.com/babylance/ .
About NANN
The National Association of Neonatal Nurses (NANN) was formed in 1984 with the purpose of addressing the educational and practice needs within the evolving specialty of neonatal nursing, while giving all neonatal nurses national representation.
For more information about NANN, please visit http://www.nann.org .
About MediPurpose
Founded in 1999, MediPurpose is a leading medical device company headquartered in Singapore, with offices in the United States and Europe.
Known for its popular babyLance® heel incision device, SurgiLance® safety lancet and MediPlus™ advanced wound care products, MediPurpose has leveraged its success in the medical device industry to become a master medical product distributor that provides unique solutions for both medical product manufacturers and medical product distributors.
MediPurpose's Medical Device Innovation division offers angel funding and developmental expertise for new medical device inventors and innovative medical product companies that seek entrance into new medical device markets.
For more information about MediPurpose’s medical products and solutions for inventors, innovators, manufacturers and distributors, please visit http://www.medipurpose.com .
###
Contact
MediPurpose
Derek Rudnak
888-808-6494
www.medipurpose.com
Derek Rudnak
888-808-6494
www.medipurpose.com
Contact
Categories